BOTTIGLIERI, ACHILLE

BOTTIGLIERI, ACHILLE  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 2022 Boeri M.Lo Russo G.Manglaviti S.Beninato T.Bottiglieri A.Zattarin E.Galli E. G.de Braud F. G. M. + Article (author) -
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 2022 Manglaviti S.Beninato T.Zattarin E.Lobefaro R.Bottiglieri A.Apollonio G.de Braud F. G. M. + Article (author) -
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 2021 Ligorio F.Zambelli L.Bottiglieri A.Zattarin E.Ottini A.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 2021 Cavalieri SColombo EBottiglieri AMassa GPlatini FOttini AZattarin EResteghini CAlfieri SDi Martino VLicitra L. + Article (author) -
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 2021 Bottiglieri A.Lobefaro R.Nichetti F.Manglaviti S.de Braud F. + Article (author) -
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 2021 Cavalieri S.Bottiglieri A.Colombo E.Licitra L. + Article (author) -
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 2020 Ligorio, F.Zambelli, L.Bottiglieri, A.Castagnoli, L.Zattarin, E.Vingiani, A.Pruneri, G.de Braud, F.Vernieri, C. + Article (author) -